Commodore Capital as of Dec. 31, 2023
Portfolio Holdings for Commodore Capital
Commodore Capital holds 32 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 11.4 | $131M | 4.7M | 27.50 | |
| Xenon Pharmaceuticals (XENE) | 8.7 | $100M | 2.2M | 46.06 | |
| Nuvalent Inc-a (NUVL) | 8.6 | $98M | 1.3M | 73.59 | |
| Vera Therapeutics Cl A (VERA) | 7.3 | $84M | 5.5M | 15.38 | |
| Rhythm Pharmaceuticals (RYTM) | 6.2 | $71M | 1.6M | 45.97 | |
| Vaxcyte (PCVX) | 6.0 | $69M | 1.1M | 62.80 | |
| Cabaletta Bio (CABA) | 3.8 | $43M | 1.9M | 22.70 | |
| Immunovant (IMVT) | 3.7 | $42M | 1.0M | 42.13 | |
| Miragen Therapeutics (VRDN) | 3.7 | $42M | 1.9M | 21.78 | |
| Arvinas Ord (ARVN) | 3.6 | $41M | 1.0M | 41.16 | |
| Spyre Therapeutics Com New (SYRE) | 3.5 | $41M | 1.9M | 21.52 | |
| Enliven Therapeutics (ELVN) | 3.5 | $40M | 2.9M | 13.84 | |
| Cogent Biosciences (COGT) | 2.9 | $33M | 5.6M | 5.88 | |
| Alpine Immune Sciences | 2.7 | $31M | 1.6M | 19.06 | |
| Soleno Therapeutics (SLNO) | 2.5 | $28M | 700k | 40.25 | |
| Celldex Therapeutics Com New (CLDX) | 2.4 | $28M | 702k | 39.66 | |
| Celcuity (CELC) | 2.2 | $26M | 1.8M | 14.57 | |
| Rayzebio | 2.1 | $24M | 384k | 62.17 | |
| Pharvaris N V (PHVS) | 2.0 | $22M | 800k | 28.05 | |
| C4 Therapeutics Com Stk (CCCC) | 1.9 | $22M | 3.8M | 5.65 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.8 | $20M | 1.9M | 10.70 | |
| Nkarta (NKTX) | 1.6 | $18M | 2.7M | 6.60 | |
| Kura Oncology (KURA) | 1.6 | $18M | 1.2M | 14.38 | |
| Harpoon Therapeutics Com New | 1.5 | $17M | 1.5M | 11.37 | |
| Akero Therapeutics (AKRO) | 1.2 | $13M | 565k | 23.35 | |
| Dyne Therapeutics (DYN) | 1.0 | $12M | 900k | 13.30 | |
| Vistagen Therapeutics Ord (VTGN) | 0.7 | $8.1M | 1.6M | 5.14 | |
| Third Harmonic Bio (THRD) | 0.7 | $7.8M | 707k | 10.97 | |
| Adverum Biotechnologies | 0.7 | $7.5M | 10M | 0.75 | |
| Apogee Therapeutics (APGE) | 0.6 | $7.0M | 250k | 27.94 | |
| Sab Biotherapeutics (SABS) | 0.1 | $1.3M | 1.8M | 0.69 | |
| Dbv Technologies S A Sponsored Adr | 0.0 | $88k | 93k | 0.95 |
